Erythromycin Ethylsuccinate For Suspension
Product Images NDC 85742-030

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin Ethylsuccinate (NDC 85742-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cadila-cont-label-200mg-5ml.jpg (Cadila Cont Label 200mg 5ml)

This text appears to be a detailed description of a medication called Erythromycin Suspension, with instructions for preparation and dosage. The medication is to be stored at specific temperatures both before and after mixing, and there are directions to shake well before use. The dosage is provided in terms of milligrams per kilogram of body weight. The text also includes information about the manufacturer and distributor of the medication.*

FDA Label Image

Cadila-cont-label-400mg-5ml.jpg (Cadila Cont Label 400mg 5ml)

This text refers to the directions, dosage, and administration of Erythromycin Ethylsuccinate oral suspension, USP. It provides information on how to use and store the medication, including dosage instructions, recommended storage conditions, and details of the manufacturer. The text also includes the strength of the medication (400 mg per 5 mL) and mentions that it should be taken with or without meals.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.